Segmental duplications (SDs) are involved in the reshaping and evolutionary development of primate genome architecture. Their intrinsic property to promote genomic instability facilitates genome rearrangements, thereby contributing to karyotype diversity in primates. However, comparative analyses of SDs based on whole-genome shotgun assemblies of primate genomes may lead to a distorted view of their evolutionary dynamics as this method will incorrectly assemble or simply not represent these regions. Therefore high-quality sequences of chromosomally assigned SDs are indispensable for unraveling the amplification and dispersal pattern of SDs during primate evolution. Here, we use an updated version of the ancestral duplicon state of the non-palindromic SDs of all 4 human Y-chromosome euchromatin/heterochromatin transition regions to perform a survey of duplicons genome-wide across 7 primate species. By adjusting experimental conditions to the mean nucleotide sequence divergence to human we identified 11,075 BAC clones carrying primate orthologs or paralogs of human Y chromosome-derived duplicons. Preliminary results indicate lineage-specific amplification of duplicons in prosimians and gibbons. This BAC-based framework represents the first complete set of a defined number of duplicons over 60 million years of primate evolution. Comparative sequence analysis of this genetic resource can contribute to our deeper understanding of the impact of segmental duplications on primate genome evolution.

Keywords:
Evolution, Primates, Segmental duplication, Y chromosome
1.
Bailey JA, Eichler EE: Genome-wide detection and analysis of recent segmental duplications within mammalian organisms. Cold Spring Harbor Symp Quant Biol 68:115–124 (2003).
2.
Bailey JA, Eichler EE: Primate segmental duplications: crucibles of evolution, diversity and disease. Nat Rev Genet 7:552–564 (2006).
3.
Carbone L, Vessere GM, ten Hallers BF, Zhu B, Osoegawa K, et al: A high-resolution map of synteny disruptions in gibbon and human genomes. PLoS Genet 29:e223 (2006).
4.
Chimpanzee Sequencing and Analysis Consortium: Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437:69–87 (2005).
5.
Dumas L, Kim YH, Karimpour-Fard A, Cox M, Hopkins J, et al: Gene copy number variation spanning 60 million years of human and primate evolution. Genome Res 17:1268–1277 (2007).
6.
Eichler EE: Segmental duplications: what’s missing, misassigned, and misassembled – and should we care? Genome Res 11:653–656 (2001).
7.
Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13 (1983).
8.
Girirajan S, Chen L, Graves T, Marques-Bonet T, Ventura M, et al: Sequencing human-gibbon breakpoints of synteny reveals mosaic new insertions at rearrangement sites. Genome Res19:178–190 (2009).
9.
Goodman M: The genomic record of humankind’s evolutionary roots. Am J Hum Genet 64:31–39 (1999).
10.
Goodman M: Moving primate genomics beyond the chimpanzee genome. Trends Genet 21:511–517 (2005).
11.
Green P: 2x genomes – does depth matter? Genome Res 17:1547–1549 (2007).
12.
Harris RA, Rogers J, Milosavljevic A: Human-specific changes of genome structure detected by genomic triangulation. Science 316:235–237 (2007).
13.
Jiang Z, Tang H, Ventura M, Cardone MF, Marques-Bonet T, et al: Ancestral reconstruction of segmental duplications reveals punctuated cores of human genome evolution. Nat Genet 39:1361–1368 (2007).
14.
Kirsch S, Münch C, Jiang Z, Cheng Z, Chen L, et al: Evolutionary dynamics of segmental duplications from human Y-chromosomal euchromatin/heterochromatin transition regions. Genome Res 18:1030–1042 (2008).
15.
Ma J, Zhang L, Suh BB, Raney BJ, Burhans RC, et al: Reconstructing contiguous regions of an ancestral genome. Genome Res 16:1441–1444 (2006).
16.
Mansfield K, Tardif S, Eichler EE: White paper for complete sequencing of the common marmoset (Callithrix jacchus) genome (2004). (http://www.genome.gov/Pages/Research/Sequencing/SeqProposals/MarmosetSeq.pdf)
17.
Marques-Bonet T, Kidd JM, Ventura M, Graves TA, Cheng Z, et al: A burst of segmental duplications in the genome of the African great ape ancestor. Nature 457:877–881 (2009).
18.
Meinkoth J, Wahl G: Hybridization of nucleic acids immobilized on solid supports. Anal Biochem 138:267–284 (1984).
19.
Misceo D, Capozzi O, Roberto R, Dell’Oglio MP, Rocchi M, et al: Tracking the complex flow of chromosome rearrangements from the Hominoidea Ancestor to extant Hylobates and Nomascus Gibbons by high-resolution synteny mapping. Genome Res 18:1530–1537 (2008).
20.
Myers G: Whole-genome DNA sequencing. Comput Sci Eng 1:33–43 (1999).
21.
Rhesus Macaque Genome Sequencing and Analysis Consortium: Evolutionary and biomedical insights from the rhesus macaque genome. Science 316:222–234 (2007).
22.
Roberto R, Capozzi O, Wilson RK, Mardis ER, Lomiento M, et al: Molecular refinement of gibbon genome rearrangements. Genome Res 17:249–257 (2007).
23.
She X, Horvath JE, Jiang Z, Liu G, Furey TS, et al: The structure and evolution of centromeric transition regions within the human genome. Nature 430:857–864 (2004).
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.